Primary Insulin-like Growth Factor-1 Deficiency
Also known as: Primary insulin like growth factor-1 deficiency
Drug | Drug Name | Drug Description |
---|---|---|
DB01277 | Mecasermin | A recombinant insulin-like growth factor-1 used for the long-term treatment of growth failure in pediatric patients with primary IGF-1 deficiency or with growth hormone gene deletion due to the development of neutralizing antibodies to GH. |
DB14751 | Mecasermin rinfabate | Mecasermin rinfabate was approved for treatment of severe primary insulin-like growth factor (IGF) deficiency or in patients with GH gene deletion who have developed antibodies to growth hormone (GH) .... |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB01277 | Mecasermin | Not Available | Terminated | 1 |